John Eu-Li Wong, CTRG—National University Hospital / National University of Singapore

“Since returning from the United States after several years in New York, I have been struck by the differences between cancer in the US and Southeast Asia. The problem is an enormous one here, with cancer being the leading cause of death in Singapore, and one of the leading causes for other countries in the area. Despite economic fluctuations, patients and their tightly-knit family units are keen to have treatment comparable to what is available in the West. This has led to a tremendous demand to be enrolled in well-run drug trials when standard therapy either has poor results, or when it fails.
Read more...
 

Doctors' Access
Lost Password?
PDF Print E-mail

The Cancer Therapeutics Research Group (CTRG) was formed in October 1997 by Professor John Wong (National University Hospital and National University of Singapore) and Professor James Bishop (Sydney Cancer Centre and University of Sydney) to develop new therapeutic strategies for cancers common to Asia- Pacific. 

This resulted in a joint research group, between National University Hospital/ National University of Singapore; Sydney Cancer Centre/ University of Sydney; Johns Hopkins International Medical Centre; Chinese University Hong Kong; National Cancer Centre, Singapore; Yonsei Cancer Centre, Korea; and Sir Charles Gairdner Hospital, Perth Australia, which performs clinical trials on new anti-cancer drugs in Asia-Pacific, and aims to be the equivalent of oncology cooperative groups in the USA.
 
[ Back ]

Our Research & Publications

(c) 2007 CTRG